Omicron-specific Sinopharm Covid vaccine candidates cleared for clinical trial | Malay Mail
BEIJING, April 16 — Covid-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said today.
The two candidates from units of Sinopharm subsidiary China National Biotec Group and one from Sinovac contain inactivated or “killed” coronavirus and are similar to vaccines that the companies are supplying in China and overseas, the companies said in statements. Sinovac said it will push forward studies in its existing CoronaVac vaccine’s protection against emerging variants.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Omicron-specific Sinopharm vaccine candidates set for clinical trialApproved for clinical trials as boosters in Hong Kong.
Read more »
S.Korea to lift most Covid curbs from next week as Omicron wanes | Malay MailSEOUL, April 15 — South Korea said on Friday it will drop most Covid-19 pandemic-related restrictions next week, including a midnight curfew on eateries, as the Omicron surge in cases shows signs of waning, although people will still have to wear masks. From April 18, the midnight curfew on...
Read more »
Covid-19: Second booster is free and voluntary, says ProtectHealthPETALING JAYA: Getting a second Covid-19 vaccine booster dose is voluntary and free of charge under the National Covid-19 Immunisation Programme (PICK), says ProtectHealth.
Read more »
Poorer nations shun AstraZeneca Covid vaccine, says document | Malay MailBRUSSELS, April 14 — Poorer nations have refused tens of millions of AstraZeneca Covid-19 vaccines from the global programme Covax, a document shows, the latest sign that its short shelf life is sapping demand for the shot. Covax is the world’s largest Covid-19 vaccine-sharing programme. It has...
Read more »
Kaneka new PCR test kit can simultaneously detect Covid-19 Omicron, Delta variantsThis test kit uses a proprietary reagent developed using Kaneka's molecular testing-related technologies to detect the presence of three variants with a single PCR test. theSun thesundaily RT-PCRKit
Read more »